Dr. Lesmana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 513-636-4315Fax+1 513-636-7905
Summary
- Dr. Harry Lesmana is a dual-certified pediatric hematologist/oncologist and clinical geneticist. He received his medical degree from University of Indonesia and has been in practice since 2012. He specializes in cancer genetics, bone marrow failure and various hereditary blood disorders. He serves as director of Pediatric Cancer Predisposition and Immunohematology Program at Cleveland Clinic.
Education & Training
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 2017 - 2020
- Cincinnati Children's Hospital Medical CenterResidency, Medical Genetics and Genomics, 2012 - 2017
- University of IndonesiaClass of 2008
Certifications & Licensure
- OH State Medical License 2019 - 2025
- PA State Medical License 2016 - 2024
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Research Training Award for Fellows American Society of Hematology, 2019
- Blackfan Research Award Cincinnati Children's Hospital Medical Center, 2017
- Hematology Opportunities for the Next Generation of Research Scientists American Society of Hematology, 2016
Clinical Trials
- Investigation of the Genetics of Hematologic Diseases Start of enrollment: 2016 Jun 17
Publications & Presentations
PubMed
- JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms.Brittany L Stewart, Hetty E Carraway, Adriana L Alvarez, Harry Lesmana, John C Molina
Blood Advances. 2024-12-10 - Sphingosine phosphate lyase insufficiency syndrome as a primary immunodeficiency state.Saber Gharagozlou, NicolaA M Wright, Luis Murguia-Favela, Juliette Eshleman, Julian Midgley
Advances in Biological Regulation. 2024-12-01 - Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders.Yoshiko Nakano, Roland P Kuiper, Kim E Nichols, Christopher C Porter, Harry Lesmana
Clinical Cancer Research. 2024-11-15
Journal Articles
- Neonatal myocardial infarction in Williams–Beuren syndromeHarry Lesmana, Lisa Dyer, David L.S. Morales, Thomas D. Ryan, Robert J. Hopkin, Progress in Pediatric Cardiology, 1/7/2019
Abstracts/Posters
- Disease Modeling and Phenotype Rescue Using Inducible Pluripotent Stem Cells from Patients with Diamond-Blackfan AnemiaHarry Lesmana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- RGL2 Deficiency Impairs Human Erythropoiesis By Altering Terminal Erythroid Differentiation and ApoptosisHarry Lesmana, MD , Georgios E Christakopoulos, MD , Mary Risinger , Haripriya Sakthivel , Omar Niss, MD , Theodosia A. Kalfa, MD PhD, Blood, 12/7/2017
- Clinical Application of Massively Parallel Sequencing in the Diagnosis of Hereditary Hemolytic and Dyserythropoietic AnemiasHarry Lesmana, MD , Georgios E Christakopoulos, MD , Katie Giger Seu, PhD , Mary Risinger, PhD , Hatice Duzkale, MD MPH, PhD , Neha Dagaonkar , Kejian Zhang, MD , Theo..., Blood, 12/2/2016
Grant Support
- Research Training Award For FellowsASH2019–2020
- HONORS (Hematology Opportunities for the Next Generation of Research Scientists)American Society of Hematology2016–2017
Professional Memberships
- Fellow
- Member
- American Society of Human GeneticsMember
- Clinical Immunology SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: